Millions left behind as diabetes drives surge in insulin demand


FILE PHOTO: An employee walks in the insulin production plant of Danish multinational pharmaceutical company Novo Nordisk in Chartres, north-central France, April 21, 2016. REUTERS/Guillaume Souvant/Pool/File Photo LONDON: A global diabetes epidemic is fuelling record demand for insulin but tens of millions will not get the injections they need unless there is a dramatic improvement in access and affordability, a new study concluded on Wednesday Diabetes - which can lead to blindness, kidney failure, heart problems, neuropathic pain and amputations - now affects 9 per cent of all adults worldwide, up from 5 per cent in 1980.



from Biotech News